Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

121 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Disease-modifying therapies for Parkinson disease: lessons from multiple sclerosis.
Kalia LV, Asis A, Arbour N, Bar-Or A, Bove R, Di Luca DG, Fon EA, Fox S, Gan-Or Z, Gommerman JL, Kang UJ, Klawiter EC, Koch M, Kolind S, Lang AE, Lee KK, Lincoln MR, MacDonald PA, McKeown MJ, Mestre TA, Miron VE, Ontaneda D, Rousseaux MWC, Schlossmacher MG, Schneider R, Stoessl AJ, Oh J. Kalia LV, et al. Among authors: arbour n. Nat Rev Neurol. 2024 Dec;20(12):724-737. doi: 10.1038/s41582-024-01023-0. Epub 2024 Oct 7. Nat Rev Neurol. 2024. PMID: 39375563 Review.
The Canadian Prospective Cohort Study to understand progression in multiple sclerosis: baseline characteristics.
Oh J, Arbour N, Giuliani F, Guenette M, Kolind S, Lynd L, Marrie RA, Metz LM, Prat A, Schabas A, Smyth P, Tam R, Traboulsee A, Yong VW, Patten SB. Oh J, et al. Among authors: arbour n. Ther Adv Neurol Disord. 2024 Sep 12;17:17562864241273045. doi: 10.1177/17562864241273045. eCollection 2024. Ther Adv Neurol Disord. 2024. PMID: 39282637 Free PMC article.
Efficacy of cannabinoids compared to the current standard treatments on symptom relief in persons with multiple sclerosis (CANSEP trial): study protocol for a randomized clinical trial.
Zertal A, Alami Marrouni K, Arbour N, Jutras-Aswad D, Pomey MP, Rouleau I, Prat A, Larochelle C, Beaulieu P, Chamelian L, Sylvestre MP, Morin D, Ouellette JS, Fréjeau N, Duquette P. Zertal A, et al. Among authors: arbour n. Front Neurol. 2024 Jul 24;15:1440678. doi: 10.3389/fneur.2024.1440678. eCollection 2024. Front Neurol. 2024. PMID: 39114536 Free PMC article.
Maraviroc and JC virus-associated immune reconstitution inflammatory syndrome.
Giacomini PS, Rozenberg A, Metz I, Araujo D, Arbour N, Bar-Or A; Maraviroc in Multiple Sclerosis–Associated PML–IRIS (MIMSAPI) Group. Giacomini PS, et al. Among authors: arbour n. N Engl J Med. 2014 Jan 30;370(5):486-8. doi: 10.1056/NEJMc1304828. N Engl J Med. 2014. PMID: 24476450 Free PMC article. No abstract available.
MCAM+ brain endothelial cells contribute to neuroinflammation by recruiting pathogenic CD4+ T lymphocytes.
Charabati M, Zandee S, Fournier AP, Tastet O, Thai K, Zaminpeyma R, Lécuyer MA, Bourbonnière L, Larouche S, Klement W, Grasmuck C, Tea F, Zierfuss B, Filali-Mouhim A, Moumdjian R, Bouthillier A, Cayrol R, Peelen E, Arbour N, Larochelle C, Prat A. Charabati M, et al. Among authors: arbour n. Brain. 2023 Apr 19;146(4):1483-1495. doi: 10.1093/brain/awac389. Brain. 2023. PMID: 36319587 Free PMC article.
COVID-19 Induces Neuroinflammation and Suppresses Peroxisomes in the Brain.
Roczkowsky A, Limonta D, Fernandes JP, Branton WG, Clarke M, Hlavay B, Noyce RS, Joseph JT, Ogando NS, Das SK, Elaish M, Arbour N, Evans DH, Langdon K, Hobman TC, Power C. Roczkowsky A, et al. Among authors: arbour n. Ann Neurol. 2023 Sep;94(3):531-546. doi: 10.1002/ana.26679. Epub 2023 Jun 5. Ann Neurol. 2023. PMID: 37190821
Single-Cell Transcriptomics Identifies Brain Endothelium Inflammatory Networks in Experimental Autoimmune Encephalomyelitis.
Fournier AP, Tastet O, Charabati M, Hoornaert C, Bourbonnière L, Klement W, Larouche S, Tea F, Wang YC, Larochelle C, Arbour N, Ragoussis J, Zandee S, Prat A. Fournier AP, et al. Among authors: arbour n. Neurol Neuroimmunol Neuroinflamm. 2022 Nov 29;10(1):e200046. doi: 10.1212/NXI.0000000000200046. Print 2023 Jan. Neurol Neuroimmunol Neuroinflamm. 2022. PMID: 36446612 Free PMC article.
121 results